Guangzhou, China · Founded 2007 · In IPO Registration
Manufacturer of medicines and health products intended to control drug release, sustained release and targeted drug release. Novaken Pharm is based in Guangzhou, China and was founded in 2007. Its last reported valuation was $215 million in Nov 2025. It has raised $39.1 million.
Last reported valuation
$215.1M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
—
Cap table — not yet on record
Novaken Pharm's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Novaken Pharm with a free account
·Watch Novaken Pharm: the Monday email on marks, rounds and moves
